CAS 1253186-46-7

Benzamide, 2,6-difluoro-N-[1-[(2-phenoxyphenyl)methyl]-1H-pyrazol-3-yl]-

Description:

Benzamide, 2,6-difluoro-N-[1-[(2-phenoxyphenyl)methyl]-1H-pyrazol-3-yl]- is a synthetic organic compound characterized by its complex structure, which includes a benzamide moiety and a pyrazole ring. The presence of two fluorine atoms at the 2 and 6 positions of the benzamide enhances its lipophilicity and may influence its biological activity. The compound features a phenoxyphenyl group, which contributes to its potential interactions in biological systems, possibly affecting its pharmacological properties. This compound is likely to exhibit moderate to high stability under standard conditions, but its reactivity can be influenced by the functional groups present. As a member of the benzamide class, it may exhibit properties such as acting as a potential inhibitor or modulator in various biochemical pathways. Its specific applications and effects would depend on further empirical studies, including its solubility, melting point, and interaction with biological targets. Overall, this compound represents a class of molecules with potential significance in medicinal chemistry and drug development.

Formula: C₂₃H₁₇F₂N₃O₂

Synonyms:

• GSK-5503A
• Benzamide, 2,6-difluoro-N-[1-[(2-phenoxyphenyl)methyl]-1H-pyrazol-3-yl]-

2,6-Difluoro-N-(1-(2-phenoxybenzyl)-1H-pyrazol-3-yl)benzamide

CAS: 1253186-46-7

2,6-Difluoro-N-(1-(2-phenoxybenzyl)-1H-pyrazol-3-yl)benzamide is a peptide that is used as a research tool. It has been shown to activate the antibody and cytotoxic T cells in mice, which may be due to its ability to inhibit the interaction of certain proteins. This peptide also has been shown to have an effect on ion channels, such as Kv1.7 and Kv1.5, which are important for proper nerve function. 2,6-Difluoro-N-(1-(2-phenoxybenzyl)-1H-pyrazol-3-yl)benzamide binds to receptors on the surface of cells and can act as a ligand or antagonist. It has been shown to inhibit protein interactions with other proteins, such as Fyn tyrosine kinase and Lck tyrosine kinase in vitro

Formula: C₂₃H₁₇F₂N₃O₂

Purity: Min. 95%

Molecular weight: 405.4 g/mol

Ref: 3D-DAC18646

GSK-5503A

CAS: 1253186-46-7

GSK-5503A is a novel channel blocker of CRAC.

Formula: C₂₃H₁₇F₂N₃O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 405.4

Ref: TM-T24112